drugset / Trial / NCT02387762
ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is evaluating the safety, pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of ACP-196 in subjects with Rheumatoid Arthritis on background Methotrexate.
Timeline
- Start
- 2015-04
- Primary completion
- 2016-05
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acalabrutinib | Small molecule | 15 mg | Oral |